Toggle Nav
A UCL Cancer Institute spin-out company Engineering T-cell CAR products that can specifically and safely destroy malignant cells Developing & commercialising next-generation engineered T-cell therapies for haematological and solid tumours

Engineering the Immune System to Combat Cancer

Autolus™ is a private biopharmaceutical company, focused on the development and commercialisation of engineered T-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers.